It's supported by more than 100 developing countries, many of whom have not yet made a meaningful start to their vaccination campaigns. But drugs companies say manufacturing capacity and ingredients shortages, not patents are proving to be the main bottlenecks. Britain, the European Union and the United States all oppose the proposal and are likely to block its passage in the WTO. --BBC--